Join Drs Ginette Okoye and Rebecca Manno as they discuss the connection between HS and arthritis, practice pearls, and novel insights uncovered from clinic work in the USVI.

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers ...

The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 years and older.

Guselkumab treatment was associated with improvements in 3 biomarkers associated with systemic inflammation among patients with plaque psoriasis.

Dry brushing your skin can help you exfoliate and lead to smoother skin. As long as you don't have any health conditions that ...

Acral peeling skin syndrome causes skin peeling on the hands and feet. It’s painless, but symptoms may cause distress. Learn ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Preclinical Psoriasis Data Presented at SID Annual Meeting On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation ...